İRKEÇ, C. Et Al. 2017. Serum fractalkine levels in patients with vascular dementia,Alzheimer’s disease and mild cognitive impairment. The world congress of Neurology (WCN) .

İRKEÇ, C., ALTIPARMAK, T., & FİDAN, I., (2017). Serum fractalkine levels in patients with vascular dementia,Alzheimer’s disease and mild cognitive impairment . The world congress of Neurology (WCN)

İRKEÇ, CEYLA, TAYLAN ALTIPARMAK, And IŞIL FİDAN. "Serum fractalkine levels in patients with vascular dementia,Alzheimer’s disease and mild cognitive impairment," The world congress of Neurology (WCN), 2017

İRKEÇ, CEYLA Et Al. "Serum fractalkine levels in patients with vascular dementia,Alzheimer’s disease and mild cognitive impairment." The world congress of Neurology (WCN) , 2017

İRKEÇ, C. ALTIPARMAK, T. And FİDAN, I. (2017) . "Serum fractalkine levels in patients with vascular dementia,Alzheimer’s disease and mild cognitive impairment." The world congress of Neurology (WCN) .

@conferencepaper{conferencepaper, author={CEYLA İRKEÇ Et Al. }, title={Serum fractalkine levels in patients with vascular dementia,Alzheimer’s disease and mild cognitive impairment}, congress name={The world congress of Neurology (WCN)}, city={}, country={}, year={2017}}